Trumpova administracija je predstavila kontroverzni plan čiji je cilj smanjenje plaćanja bolnicama za određene medicinske usluge, posebno postupke snimanja, što bi moglo značajno utjecati na troškove zdravstvene zaštite za starije osobe.
Prema izvještajima, predložene promjene najavljene su u srpnju 2026. godine, što je značajan pomak u načinu na koji Medicare financira bolničke dijagnostičke usluge.
U središtu kontroverze leži 340B Program popusta na lijekove, savezna inicijativa osmišljena za pružanje popusta na lijekove bolnicama sigurnosnih mreža koje služe bolesnicima s niskim prihodima.
Iako je program 340B namijenjen za podršku bolnicama u zajednici, stav administracije sugerira prednost tržišnim modelima cijena, što izaziva zabrinutost o dugoročnoj održivosti takvih programa.
Neprofitne i akademske bolnice, koje se u velikoj mjeri oslanjaju na program 340B, izrazile su snažno protivljenje, upozoravajući da bi ih promjene mogle prisiliti da smanje usluge ili čak zatvore vrata.
Reakcije zainteresiranih strana bile su mješovite. Advokatske skupine koje predstavljaju bolnice s sigurnosnim mrežama nazvale su prijedloge "nesrazmjerno štetnim" i upozorile na potencijalnu krizu za nedostupne zajednice. U međuvremenu, predstavnici industrije pohvalili su reforme kao nužnu korekciju zastarjelih modela plaćanja.
Budućnost ovih politika ostaje neizvjesna. Predložena pravila vjerojatno će se suočiti s pravnim izazovima i zahtijevati odobrenje regulatornih tijela prije provedbe. Osim toga, politička klima koja okružuje reformu zdravstvene zaštite nastavlja se razvijati, s potencijalnim zakonodavnim djelovanjem ili izvršnim nalogima koji oblikuju putanju ovih inicijativa.
2 izvještaja
The HillNeovisanSredinajučerThe Trump administration has proposed a rule from the Centers for Medicare and Medicaid Services (CMS) that would reduce hospital payments for certain imaging services. The change aims to equalize payments between hospitals and outpatient facilities, potentially leading to lower costs for seniors who receive routine imaging procedures. While the proposal could result in reduced expenses for patients, it raises concerns about the financial impact on hospitals and the quality of care. The move reflects broader efforts to reform healthcare spending and shift some services away from inpatient settings.
Procjena pristranosti (Sredina): The article presents the proposal as a policy initiative without overtly criticizing or praising the administration's stance. It focuses on the potential effects of the policy rather than taking a clear ideological position. The framing remains neutral, emphasizing the administrative action and its'
STAT NewsNeovisanSredinajučerMedicare has proposed reducing payments to hospitals for drugs purchased through the 340B drug discount program by over a third starting next year. This comes after Medicare's surveys indicated that some patients were paying more for these drugs than the hospitals did. Under the new proposal, Medicare would reimburse hospitals at the average sales price of the drugs minus 33.4%, significantly lower than the current rate of that price plus 6%. The proposal is part of a broader rule on hospital outpatient payments and has sparked controversy, with nonprofit and academic hospitals criticizing it for potentially harming safety-net providers. These hospitals are the only ones eligible for the 340B program, while for-profit hospitals would see a 7.4% pay increase under the same adjustment.
Procjena pristranosti (Sredina): The article presents the Medicare proposal and includes reactions from both supporters and critics of the 340B program. It does not exhibit clear bias toward either side, providing information on the potential impacts on different types of hospitals without overtly favoring one perspective over the.
★
Neka vijesti ostanu poštene.
ObjectiveNews financiraju čitatelji i bez oglasa je – pristranost vam pokazujemo, ne skrivamo. Podržite neovisno novinarstvo za 5 €/mjesec.
Postani podupiratelj
United States
